Spectralys Biotech SRL
1.0 FTESpectralys Biotech reported total assets of 444,695 € at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Jun 2026), with 1 full-time equivalent.
The score of Spectralys Biotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +40 % Total assets +21 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Spectralys Biotech's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 58,165 € | ||||
| Equity | 313,008 € | ||||
| Cash | 146,762 € | ||||
| EBITDA | 70,334 € | ||||
| Total assets | 444,695 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 04 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jun 2022
Spectralys Biotech's financial analysis
- Solvency70.4%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Spectralys Biotech
Spectralys Biotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0712.775.992
- VAT number
- BE0712775992
- Peppol
- Registered · 0208:0712775992 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Oct 2018
- Registered office
- 6041 Charleroi
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 04 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Spectralys Biotech (SRL) has been based in Charleroi since 2018, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 58,165 € and equity of 313,008 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 70.4%, above the median of its sector (58.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Spectralys Biotech
Companies in the same business, of comparable size and area, outside its group.
- care2trans Research and experimental development on natural sciences and engineering Merelbeke-Melle · balance sheet 817,653 €
- Lavima fertility Research and experimental development on natural sciences and engineering Aalst · balance sheet 863,324 €
- M. d'O Diagnostic imaging services and medical laboratory activities Ternat · balance sheet 378,604 €
- SciLife Consulting Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 198,474 €
- AnaLIStics Research and experimental development on natural sciences and engineering Kontich · balance sheet 208,698 €
- Cell-Cell Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet 990,571 €
- Ferrons Research and experimental development on natural sciences and engineering Ternat · balance sheet 231,903 €
- Abbio Diagnostic imaging services and medical laboratory activities Watermael-Boitsfort · balance sheet 388,415 €
Frequently asked questions about Spectralys Biotech
What is the revenue of Spectralys Biotech?
Spectralys Biotech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Spectralys Biotech?
In Belgium, the VAT number is the company number prefixed with BE: BE0712775992 for Spectralys Biotech, if the company is VAT-registered. Its company number (CBE) is 0712.775.992.
Where is the registered office of Spectralys Biotech?
According to the CBE register, the registered office of Spectralys Biotech is in 6041 Charleroi.
What is the equity of Spectralys Biotech?
At the close of the 2025 financial year, the equity of Spectralys Biotech amounts to 313,008 €, a solvency of 70.4% of total assets.
How many people work at Spectralys Biotech?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Spectralys Biotech?
The register lists 1 active mandates at Spectralys Biotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Spectralys Biotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →